A detailed history of Bank Of America Corp transactions in Beyond Spring Inc. stock. As of the latest transaction made, Bank Of America Corp holds 8,000 shares of BYSI stock, worth $16,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,000
Previous 12,994 38.43%
Holding current value
$16,800
Previous $46,000 58.7%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.76 - $3.6 $8,789 - $17,978
-4,994 Reduced 38.43%
8,000 $19,000
Q1 2024

May 15, 2024

BUY
$0.85 - $3.63 $4,017 - $17,159
4,727 Added 57.18%
12,994 $46,000
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.12 $89 - $148
133 Added 1.64%
8,267 $7,000
Q2 2023

Aug 14, 2023

SELL
$0.89 - $1.39 $23,350 - $36,468
-26,236 Reduced 76.33%
8,134 $9,000
Q1 2023

May 12, 2023

BUY
$1.06 - $3.05 $7,432 - $21,386
7,012 Added 25.63%
34,370 $38,000
Q4 2022

Feb 10, 2023

SELL
$0.56 - $2.61 $28,127 - $131,095
-50,228 Reduced 64.74%
27,358 $51,000
Q3 2022

Nov 14, 2022

SELL
$0.97 - $1.81 $13,873 - $25,888
-14,303 Reduced 15.57%
77,586 $77,000
Q2 2022

Aug 12, 2022

SELL
$1.13 - $2.66 $44,644 - $105,091
-39,508 Reduced 30.07%
91,889 $132,000
Q1 2022

May 16, 2022

BUY
$1.68 - $5.01 $68,604 - $204,588
40,836 Added 45.09%
131,397 $289,000
Q4 2021

Feb 08, 2022

BUY
$4.02 - $16.84 $145,061 - $607,671
36,085 Added 66.24%
90,561 $411,000
Q3 2021

Nov 15, 2021

BUY
$9.26 - $31.31 $137,270 - $464,139
14,824 Added 37.39%
54,476 $859,000
Q2 2021

Sep 13, 2021

BUY
$9.37 - $12.12 $371,539 - $480,582
39,652 New
39,652 $414,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $81.8M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.